ProNeurogen

I am seeking an ambitious co-founder for ProNeurogen, a pioneering startup that's revolutionizing the treatment of cognitive impairments caused by neurodegenerative diseases like vascular dementia and Parkinson's. Our novel pharmacological approach is also designed to effectively manage the pain associated with inflammation in conditions such as bone cancer. Our mission is to fill a gap for millions of patients struggling with these conditions where current treatments are ineffective. As a co-founder of ProNeurogen, you will have the unique opportunity to make a significant impact on the lives of these patients. Your role will involve making key decisions on strategic business direction, developing growth strategies and providing expert advice. Our team led by Dr. Meredith Hay, a visionary with over 30 years experience in neuroscience, is looking forward to welcoming a professional who shares our passion and vision. Our market consists of 30,000 patients currently in need of effective treatment. We expect to capture 2% of this market in the near future. Our drug candidates

Our startup, ProNeurogen, is focused on developing advanced pharmaceutical technology to revolutionize the treatment of cognitive impairment caused by various neurodegenerative diseases such as vascular dementia, mixed dementia, Parkinson's Disease, traumatic brain injuries and others. Additionally, our technology holds potential in effectively managing pain caused by inflammation such as the one experienced with bone cancer.

Our drug candidates address cognitive impairment and pain due to etiologies for which there are no currently approved treatments. They give time back to millions of patients and their loved ones